Scientific Poster , Pediatrics

AAPS 2019 Poster: Clinical formulation development for poorly soluble 14C labelled molecules

4 November 2019
Overview

Check out our latest poster from AAPS 2019, 'Clinical Formulation Development for Poorly Soluble 14C Labelled Molecules.' 

Clinical studies involving the administration of 14C radio-labeled drug substances provide critical information during development. The main application is the regulatory ADME study to assess the mass balance, routes, and rates of elimination, and to provide plasma, urine, and faecal samples for metabolite profiling and structural identification.

Download
Date
4 November 2019

Your challenges. Our solutions.

Learn more about our expertise in human ADME studies.

Quotient Sciences Logo
Human ADME, Regulatory, Dr. Adam Robinson-Miller

Assessing the Impact of the Approved FDA Guidance on Human Mass Balance Studies: How ADME programs will proceed in 2024 and beyond

By: Dr. Adam Robinson-Miller Read More
Get in touch
Humanity can't afford to wait, so neither can we.